By Professor Sean Emery

Journal articles

Gordin FM; Roediger MP; Girard P-M; Lundgren JD; Miro JM; Palfreeman A; Rodriguez-Barradas MC; Wolff MJ; Easterbrook PJ; Clezy K; Slater LN, 2008, 'Pneumonia in HIV-infected persons - Increased risk with cigarette smoking and treatment interruption', AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 178, pp. 630 - 636, http://dx.doi.org/10.1164/rccm.200804-617OC

McElrath MJ; De Rosa SC; Moodie Z; Dubey S; Kierstead L; Janes H; Defawe OD; Carter DK; Hural J; Akondy R; Buchbinder SP; Robertson MN; Mehrotra DV; Self SG; Corey L; Shiver JW; Casimiro DR, 2008, 'HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis', The Lancet, 372, pp. 1894 - 1905, http://dx.doi.org/10.1016/S0140-6736(08)61592-5

Winters B; Montaner JS; Harrigan PR; Gazzard B; Pozniak A; Miller MD; Emery S; van Leth F; Robinson P; Baxter J; Perez-Elias M; Castor D; Hammer SM; Rinehart A; Vermeiren H; Van Craenenbroeck E; Bacheler L, 2008, 'Determination of clinically relevant cutoffs for HIV-1 phenotypic resistance estimates through a combined analysis of clinical trial and cohort data', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 48, pp. 26 - 34

Lifson A; Belloso WH; Carey C; Davey R; Duprez D; El-Sadr W; Gatell J; Gey D; Hoy JF; Krum E; Nelson R; Nixon D; Paton N; Pedersen C; Perez G; Price RA; Prineas R; Rhame F; Sampson J; Worley J, 2008, 'Determination of the underlying cause of death in three multicenter international HIV clinical trials', HIV Clinical Trials, 9, pp. 177 - 185, http://dx.doi.org/10.1310/hct0903-177

Cooper DA; Emery S; Cordery D, 2008, 'Disease progression and fatal outcomes in HIV-infected patients during interruption of antiretroviral treatment', Journal of Infectious Diseases, 197, pp. 775 - 775, http://dx.doi.org/10.1086/527399

Calmy A; Carey DL; Mallon PW; Wand HC; Law MG; Cooper DA; Carr AD, 2008, 'Early changes in adipokine levels and baseline limb fat may predict HIV lipoatrophy over 2 years following initiation of antiretroviral therapy', HIV Medicine, 9, pp. 101 - 110, http://dx.doi.org/10.1111/j.1468-1293.2007.00527.x

Mallon PW; Sedwell R; Rogers GJ; Nolan D; Unemori P; Hoy JF; Samaras K; Kelleher AD; Emery S; Cooper DA; Carr AD, 2008, 'Effect of Rosiglitazone on Peroxisome Proliferator-Activated Receptor gamma Gene Expression in Human Adipose Tissue Is Limited by Antiretroviral Drug-Induced Mitochondrial Dysfunction', Journal of Infectious Diseases, 198, pp. 1794 - 1803

Lundgren JD; Babiker AG; El-Sadr W; Emery S; Grund B; Neaton JD; Neuhaus J; Phillips A, 2008, 'Inferior clinical outcome of the CD4(+) cell count guided antiretroviral treatment interruption strategy in the SMART study: Role of CD4(+) cell counts and HIV RNA levels during follow-up', Journal of Infectious Diseases, 197, pp. 1145 - 1155, http://dx.doi.org/10.1086/529523

Kuller LH; Tracy R; Belloso WH; De Wit S; Drummond F; Lane HC; Ledergerber B; Lundgren JD; Neuhaus J; Nixon D; Paton N; Neaton JD, 2008, 'Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection', PLOS Medicine, 5, pp. 1496 - 1508

Phillips AN; Carr AD; Neuhaus J; Visnegarwala F; Prineas R; Burman W; Williams IR; Drummond F; Duprez D; Belloso WH; Goebel F; Grund B; Hatzakis A; Vera J; Lundgren JD, 2008, 'Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial', Antiviral Therapy, 13, pp. 177 - 187

Emery S; Neuhaus J; Phillips A; Babiker AG; Cohen C; Gatell J; Girard P; Grund B; Law MG; Losso MH; Palfreeman A; Wood R, 2008, 'Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study', Journal of Infectious Diseases, 197, pp. 1133 - 1144, http://dx.doi.org/10.1086/586713

Mangclaviraj S; Kerr SJ; Chaithongwongwatthana S; Ananworanich J; Hirschel B; Emery S; Cooper DA; Chotnopparatpattara P; Ruxrungtham K; Phanuphak P, 2008, 'Nadir CD4 count and monthly income predict cervical squamous cell abnormalities in HIV-positive women in a resource-limited setting', International Journal of STD and AIDS, 19, pp. 529 - 532

Tedaldi E; Peters L; Neuhaus J; Puoti M; Rockstroh J; Klein M; Dore GJ; Mocroft A; Soriano V; Clotet B; Lundgren JD, 2008, 'Opportunistic Disease and Mortality in Patients Coinfected with Hepatitis B or C Virus in the Strategic Management of Antiretroviral Therapy (SMART) Study', Clinical Infectious Diseases, 47, pp. 1468 - 1475

Carey DL; Liew S; Emery S, 2008, 'Restorative interventions for HIV facial lipoatrophy', AIDS Reviews, 10, pp. 116 - 124

El-Sadr W; Grund B; Neuhaus J; Babiker AG; Cohen C; Darbyshire JH; Emery S; Phillips A; Lundgren JD; Neaton JD, 2008, 'Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy - a randomized trial', Annals of Internal Medicine, 149, pp. 289 - W62

Lundgren JD; Neuhaus J; Babiker AG; Cooper DA; Duprez D; El-Sadr W; Emery S; Gordin F; Kowalska J; Prineas R; Reiss P; Sabin C; Tracy R; Weber R; Grund B; Phillips AN; Neaton JD, 2008, 'Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients.', AIDS, 22, pp. F17 - F24

Fox Z; Phillips AN; Cohen C; Neuhaus J; Baxter J; Emery S; Hirschel B; Hullsiek K; Stephan C; Lundgren JD, 2008, 'Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen', AIDS, 22, pp. 2279 - 2289

Silverberg MJ; Neuhaus J; Bower M; Gey D; Hatzakis A; Henry K; Hidalgo J; Lourtau L; Neaton JD; Tambussi G; Abrams DI, 2007, 'Risk of cancers during interrupted antiretroviral therapy in the SMART study', AIDS, 21, pp. 1957 - 1963, http://dx.doi.org/10.1097/QAD.0b013e3282ed6338

Ellis KJ; Grund B; Visnegarwala F; Thackeray L; Miller CG; Chesson CE; El-Sadr W; Carr A, 2007, 'Visceral and subcutaneous adiposity measurements in adults: Influence of measurement site', Obesity, 15, pp. 1441 - 1447, http://dx.doi.org/10.1038/oby.2007.172

Fox Z; Antunes F; Davey R; Gazzard B; Klimas N; Labriola A; Losso M; Neaton JD; Phillips A; Ruxrungtham K; Staszewski S; Weiss L; Lundgren DJ; Aguilar L; Angel EB; Aquilia S; Belloso W; Benetucci J; Bittar V; Cahn P; Casiro A; Contarelli J; Corral J; Daciuk L; David D; Ferrari I; Fridman D; Galache V; Guaragna G; Ivalo S; Laplume H; Lanusse I; Lasala MB; Lattes R; Lasovsky J; Lopardo G; Lourtau L; Lupo S; Maranzana A; Marson C; Massera L; Sanchez MDL; Somenzini C; Tocci M; Algar S; Anderson J; Baker D; Blavius K; Bloch M; Boyle M; Bradford D; Britton P; Carrall L; Carr A; Chuah J; Curry M; D'Arcy-Evans C; Dobson P; Doong N; Egan C; Ferguson W; Finlayson R; French M; Frater A; Gold J; Habel P; Haig K; Holland R; Hyland N; Hoy J; Hudson J; James R; Leung J; Lowe K; MacRae K; McMurchie M; Medland N; Miller S; Murray J; Newman R; David O; Patching J; Primrose R; Ree H; Richardson R; Rogers G; Roney J; Roth N; Sarangapany J; Shaw D; Silberberg C; Skett A; Vale R; Villella C; Walker A; Watson A; Wendt N; Wood H, 2007, 'Predictors of CD4 count change over 8 months of follow up in HIV-1-infected patients with a CD4 count ≥ 300 cells/μL who were assigned to 7.5 MIU interleukin-2', HIV Medicine, 8, pp. 112 - 123, http://dx.doi.org/10.1111/j.1468-1293.2007.00440.x

Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A, 2007, 'Erratum: Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: Associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and hypoadiponectinemia (Diabetes Care (2007) 30, (113-119))', Diabetes Care, 30, pp. 455, http://dx.doi.org/10.2337/dc07-er02

Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A, 2007, 'Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and hypoadiponectinemia (vol 30, pg 113, 2007)', DIABETES CARE, 30, pp. 455 - 455, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000244024100062&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Byakwaga H; Zhou J; Law MG; Emery S; Mallon PW; Cooper DA, 2007, 'Effect of nucleoside reverse transcriptase inhibitors (NRTIs) on CD4 recovery for individuals on long-term, fully suppressive antiretroviral therapy (ART)', Antiviral Therapy, 12, pp. L61 - L62, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000249773400113&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Carey DL; Baker D; Rogers G; Petoumenos K; Chuah J; Easey N; Mahon K; Cooper DA; Emery S; Carr AD, 2007, 'A randomized, multicenter, open-label study of poly-l-lactic acid for HIV-1 facial lipoatrophy', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 46, pp. 581 - 589

Murray JM; Emery S; Kelleher AD; Law MG; Chen J; Hazuda DJ; Nguyen BT; Teppler H; Cooper DA, 2007, 'Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase', AIDS, 21, pp. 2315 - 2321

Bucciardini R; Fragola V; Massella M; Polizzi C; Mirra M; Goodall RL; Carey DL; Hudson FE; Zajdenverg R; Floridia M, 2007, 'Health-related quality of life outcomes in HIV-Infected patients starting different combination regimens in a randomized multinational trial: The INITIO-QoL substudy', AIDS Research and Human Retroviruses, 23, pp. 1215 - 1222

Emery S; Kelleher AD; Workman C; Puls R; Bloch MT; Baker D; Hoy JF; Ip S; Nalliah K; Ward L; Law MG; Cooper DA, 2007, 'Influence of IFN gamma co-expression on the safety and antiviral efficacy of recombinant fowlpox virus HIV therapeutic vaccines following interruption of antiretroviral therapy', Human Vaccines, 3, pp. 260 - 267

Wand HC; Calmy A; Carey DL; Samaras K; Carr AD; Law MG; Cooper DA; Emery S, 2007, 'Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV-infected adults', AIDS, 21, pp. 2445 - 2453

Samaras K; Wand HC; Law MG; Emery S; Cooper DA; Carr AD, 2007, 'Prevalence of Metabolic Syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria', Diabetes Care, 30, pp. 113 - 119, http://dx.doi.org/10.2337/dc06-1075

Motumi N; Emery S; Lane C, 2007, 'Project phidisa: development of clinical research capacity within the South African National Defence Force', Current opinion in HIV & AIDS, 2, pp. 69 - 76

Dyer W; Pett SL; Sullivan JS; Emery S; Cooper DA; Kelleher AD; Lloyd AR; Lewin S, 2007, 'Substantial improvements in performance indicators achieved in a peripheral blood mononuclear cell cryopreservation quality assurance program using single donor samples', Clinical and Vaccine Immunology, 14, pp. 52 - 59

Larder BA; Wang D; Revell A; Montaner JS; Harrigan R; De Wolf F; Lange JM; Wegner S; Ruiz L; Perez-Elias M; Emery S; Gatell J; d Arminio Monforte A; Torti C; Zazzi M; Lane C, 2007, 'The development of artificial neural networks to predict virological response to combination HIV therapy', Antiviral Therapy, 12, pp. 15 - 24

Winston A; Mallon PW; Satchell C; MacRae K; Williams KM; Schutz M; Law MG; Cooper DA; Emery S, 2007, 'The safety, efficacy, and pharmacokinetic profile of a switch in antiretroviral therapy to saquinavir, ritonavir, and atazanavir alone for 48 weeks and a switch in the saquinavir formulation', Clinical Infectious Diseases, 44, pp. 1475 - 1483

Pace C; Grady C; Wendler D; Bebchuk JD; Tavel JA; McNay LA; Forster HP; Killen J; Emanuel EJ, 2006, 'Post-trial access to tested interventions: The views of IRB/REC chair, investigators, and research participants in a multinational HIV/AIDS study', AIDS RESEARCH AND HUMAN RETROVIRUSES, 22, pp. 837 - 841, http://dx.doi.org/10.1089/aid.2006.22.837

McClelland RS; Baeten JM; Richardson BA; Lavreys L; Emery S; Mandaliya K; Ndinya-Achola JO; Overbaugh J, 2006, 'A comparison of genital HIV-1 shedding and sexual risk behavior among Kenyan women based on eligibility for initiation of HAART according to WHO guidelines', JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 41, pp. 611 - 615, http://dx.doi.org/10.1097/01.qai.0000191284.62707.b7

Samaras K; Wand HC; Law MG; Emery S; Cooper DA; Carr AD, 2006, 'Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition and metabolic parameters', Antiviral Therapy, 11, pp. L23 - L24, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000241975800055&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Hales GP; Birch C; Crowe S; Workman C; Hoy JF; Kelleher AD; Lincoln D; Lincoln D; Law MG; Emery S, 2006, 'A randomised trial comparing genotypic and virtual phenotypic interpretation of HIV drug resistance: The CREST study.', PLoS Clinical Trials, 1, pp. e18

Youle M; Emery S; Fisher M; Nelson M; Fosdick L; Janossy G; Loveday C; Sullivan AM; Herzmann C; Wand HC; Davey Jr R; Johnson MA; Tavel JA; Lane HC; Sullaphen J, 2006, 'A randomised trial of subcutaneous intermittent interleukin-2 without antiretroviral therapy in HIV-infected patients: The UK-Vanguard study.', PLoS Clinical Trials, 1, pp. e3 - e3, http://dx.doi.org/10.1371/journal.pctr.0010003

Kelleher AD; Puls R; Bebbington M; Boyle D; Kent S; Kippax SC; Purcell D; Thomson S; Wand HC; Cooper DA; Emery S; Ffrench RA, 2006, 'A randomized, placebo-controlled phase I trial of DNA prime, recombinant fowlpox virus boost prophylactic vaccine for HIV-1', AIDS, 20, pp. 294 - 297

Harrod ME; Emery S; Dwyer DE, 2006, 'Antivirals in the management of an influenza pandemic', Medical Journal of Australia, 185, pp. S58 - S61

El-Sadr W; Lundgren JD; Neaton JD; Gordin F; Abrams D; Arduino R; Babiker AG; Burman W; Clumeck N; Cohen C; Cohn D; Cooper DA; Darbyshire JH; Emery S; Fatkenheuer G; Gazzard B; Hoy JF; Klingman K; Losso MH; Markowitz N; Neuhaus J; Phillips A; Rappaport C, 2006, 'CD4+ count-guided interruption of antiretroviral treatment.', New England Journal of Medicine, 355, pp. 2283 - 2296

De Rose R; Sullivan MT; Dale CJ; Kelleher AD; Emery S; Cooper DA; Ramshaw I; Boyle D; Kent SJ, 2006, 'Dose-response relationship of DNA and recombinant fowlpox virus prime-boost HIV vaccines.', Human Vaccines, 2, pp. 134 - 136

Dwyer D; Workman C; Hales GP; Amin J; Cooper DA; Miller J; Emery S, 2006, 'Enfuvirtide in HIV-1-infected individuals changing therapy to a nucleoside reverse transcriptase inhibitor sparing regimen: The ALLIANCE Study', Antiviral Therapy, 11, pp. 409 - 419

Emery S; Dwyer DE; McKinnon M, 2006, 'Epilogue: Preparing for an influenza pandernic in Australia', Medical Journal of Australia, 185, pp. S80 - S80

Pett SL; Wand HC; Law MG; Arduino R; Lopez JC; Knysz B; Pereira L; Pollack S; Reiss P; Tambussi G, 2006, 'Evaluation of subcutaneous proleukin (interleukin-2) in a randomized international trial (ESPRIT): Geographical and gender differences in the baseline characteristics of participants', HIV Clinical Trials, 7, pp. 70 - 85

Winston A; Amin J; Marriott D; Mallon PW; Carr AD; Cooper DA; Emery S, 2006, 'Minor changes in calculated creatinine clearance and anion-gap are associated with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy', HIV Medicine, 7, pp. 105 - 111

Winston A; Amin J; Hales GP; Cooper DA; Emery S, 2006, 'Nonnucleoside reverse transcriptase inhibitor fold change or plasma concentration as a predictor of virological response over 48 weeks in highly treatment experienced HIV-positive individuals', AIDS Research and Human Retroviruses, 22, pp. 338 - 341

Lifson A; Rhame F; Belloso WH; Dragsted U; El-Sadr W; Gatell J; Hoy JF; Krum E; Nelson R; Pedersen C; Pett SL; Davey R, 2006, 'Reporting and evaluation of HIV-related clinical endpoints in two multicenter international clinical trials', HIV Clinical Trials, 7, pp. 125 - 141

Mocroft A; Neaton JD; Bebchuk JD; Staszewski S; Antunes F; Knysz B; Law MG; Phillips AN; Lundgren JD, 2006, 'The feasibility of clinical endpoint trials in HIV infection in the highly active antiretroviral treatment (HAART) era', CLINICAL TRIALS, 3, pp. 119 - 132

Puls R; Emery S, 2006, 'Therapeutic vaccination against HIV: current progress and future possibilities', Clinical Science, 110, pp. 59 - 71

Back to profile page